First Time Loading...
K

Knight Therapeutics Inc
TSX:GUD

Watchlist Manager
Knight Therapeutics Inc
TSX:GUD
Watchlist
Price: 5.82 CAD 0.87% Market Closed
Updated: May 3, 2024

Knight Therapeutics Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Knight Therapeutics Inc
Cash from Operating Activities Peer Comparison

Comparables:
BHC
WEED
CRON
C
CURA
T
TER

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
K
Knight Therapeutics Inc
TSX:GUD
Cash from Operating Activities
CA$35.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Cash from Operating Activities
$1B
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
0%
Canopy Growth Corp
TSX:WEED
Cash from Operating Activities
-CA$399.6m
CAGR 3-Years
12%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Cash from Operating Activities
-$42.8m
CAGR 3-Years
33%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Cash from Operating Activities
$56.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Terrascend Corp
CNSX:TER
Cash from Operating Activities
-$26.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Knight Therapeutics Inc's Cash from Operating Activities?
Cash from Operating Activities
35.9m CAD

Based on the financial report for Dec 31, 2023, Knight Therapeutics Inc's Cash from Operating Activities amounts to 35.9m CAD.

What is Knight Therapeutics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
-20%

Over the last year, the Cash from Operating Activities growth was -20%.